Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events
Article
Overview
Research
Additional Document Info
View All
Overview
cited authors
Guo, Mengni; VanderWalde, Ari M.; Yu, Xinhua; Vidal, Gregory A.; Tian, G. Gary
Publication Date
November 18, 2022
webpage
Web of Science
published in
CLINICAL LUNG CANCER
Journal
Research
category
ONCOLOGY
Web of Science Category
keywords
Best objective response
Immunotherapy discontinuation
Overall survival
Progression-free survival
Additional Document Info
start page
686
end page
693
volume
23
issue
8